Journey Advisory Group LLC lowered its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,818 shares of the company’s stock after selling 290 shares during […]